ITeos Therapeutics Inc [NASDAQ: ITOS] stock went on an upward path that rose over 13.44% on Tuesday, amounting to a one-week price increase of more than 18.58%.
Over the last 12 months, ITOS stock dropped by -35.60%. The one-year ITeos Therapeutics Inc stock forecast points to a potential upside of 38.67. The average equity rating for ITOS stock is currently 1.40, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $300.44 million, with 38.27 million shares outstanding and 33.10 million shares in the current float. Compared to the average trading volume of 426.49K shares, ITOS stock reached a trading volume of 11232305 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on ITeos Therapeutics Inc [ITOS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ITOS shares is $12.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ITOS stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for ITeos Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 13, 2025. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Overweight. The new note on the price target was released on August 13, 2024, representing the official price target for ITeos Therapeutics Inc stock. Previously, the target price had yet another raise to $37, while H.C. Wainwright analysts kept a Buy rating on ITOS stock.
The Average True Range (ATR) for ITeos Therapeutics Inc is set at 0.56, with the Price to Sales ratio for ITOS stock in the period of the last 12 months amounting to 8.58. The Price to Book ratio for the last quarter was 0.53, with the Price to Cash per share for the same quarter was set at 13.60.
ITOS Stock Performance Analysis:
ITeos Therapeutics Inc [ITOS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.58. With this latest performance, ITOS shares gained by 38.94% in over the last four-week period, additionally sinking by -14.49% over the last 6 months – not to mention a drop of -35.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ITOS stock in for the last two-week period is set at 62.09, with the RSI for the last a single of trading hit 66.10, and the three-weeks RSI is set at 59.25 for ITeos Therapeutics Inc [ITOS]. The present Moving Average for the last 50 days of trading for this stock 6.65, while it was recorded at 6.91 for the last single week of trading, and 9.38 for the last 200 days.
Insight into ITeos Therapeutics Inc Fundamentals:
ITeos Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 14.13 and a Current Ratio set at 14.13.
ITOS Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ITOS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ITeos Therapeutics Inc go to -5.43%.
ITeos Therapeutics Inc [ITOS] Institutonal Ownership Details
There are presently around $97.62%, or 98.74%% of ITOS stock, in the hands of institutional investors. The top three institutional holders of ITOS stocks are: BLACKROCK INC. with ownership of 3.73 million shares, which is approximately 9.3983%. RA CAPITAL MANAGEMENT, L.P., holding 3.52 million shares of the stock with an approximate value of $$52.2 million in ITOS stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$48.23 million in ITOS stock with ownership which is approximately 8.1862%.
